Analysis published 12 Oct 2026

AI-generated · cited to primary sources · not investment advice

Apollo Hospitals (508869) Nov 2025 Filing Analysis

01 · Management Credibility

Does management do what it says?

Medical Tourism Growing at 20%+ CAGR

Management expects Bangladesh patient volumes to recover, with at least 60% having returned in October, and is exploring additional international markets including Uzbekistan, Africa, Indonesia and Iraq. — target: At least 60% of Bangladesh patients returning

“Bangladesh, at least 60% has started coming back in October and we believe that we will mitigate the impact of losing one territory. Also, we are exploring new markets, including the Northern markets in Uzbekistan, etcetera. So those that are surrounding markets, Africa, some with Indonesia, Iraq.”

Apollo Hospitals · Concall Transcript · Nov 2025 · p.3

See the full cited Management analysis of Apollo Hospitals

Create free account →
02 · Business Model

How durable is the business?

Case Mix Determines ARPOB Trajectory
80/100

Higher-complexity specialties were growing faster than the hospital business overall: cardiac, oncology, neurosciences, gastroenterology and orthopaedics recorded 6% volume growth and 14% revenue growth year on year. Management attributed higher revenue per patient largely to a richer mix of cases. This is a favorable shift toward more complex care. (5 expanding)

“Cardiac, oncology, neurosciences, gastro and orthopaedics - which remain a key growth engine, delivering a 6% volume and 14% revenue growth on a year-on-year basis.”

Apollo Hospitals · Concall Transcript · Nov 2025 · p.2
Medical Tourism Growing at 20%+ CAGR
80/100

The Bangladesh patient reduction lowered Healthcare Services revenue by about 1% in Q2 FY26. Management said at least 60% of Bangladesh patient volumes had begun returning by October and described exploring other international markets, including Uzbekistan, Africa, Indonesia and Iraq. The later baseline says Bangladesh volumes had recovered to 60%–70% of their former peak and international-patient revenue was up 26% YoY, supporting a favorable recovery and diversification direction. The transcript gives no international revenue share. (2 expanding)

“The reduction in number of patients from Bangladesh has had a 1% impact on Healthcare Services revenue in Q2 FY26.”

Apollo Hospitals · Concall Transcript · Nov 2025 · p.2

See the full cited Business Model analysis of Apollo Hospitals

Create free account →
03 · Future Growth

Where does growth come from?

Average Revenue Per Occupied Bed

The supplied signal describes Q1 FY27, which is outside this November 2025 presentation. In this document, hospital revenue growth is 9% in Q2 FY26 after 10% in H1 FY26; inpatient-volume growth is about 2% in both periods, while revenue per inpatient is up about 9% in both. The latest quarter therefore shows slower revenue growth, mostly from low patient-volume growth rather than a change in revenue per patient. (1 decelerating, 1 steady, 1 new trend across 3 signals)

“Healthcare Services Revenue grew by 9% in Q2FY26 (Inpatient Volume grew by 2% ; Price of and case mix of 7%). ... Average Revenue per In patient grew by 9% to ₹173,318 in Q2FY26”

Apollo Hospitals · Investor PPT · Nov 2025 · p.15

See the full cited Future Growth analysis of Apollo Hospitals

Create free account →

AI-generated informational research only. ThesisLoop is not investment advice, a stock recommendation, or a guarantee of returns.